The shareholders of surgical visualization technology developer Mazor Robotics have approved the firm's previously announced acquisition by device manufacturer Medtronic for approximately $1.64 billion in cash.
Mazor shareholders would receive $58.20 per American depositary share or $29.25 per ordinary share, upon closing of the deal. The transaction, which remains subject to certain closing conditions, is expected to close during Medtronic's fiscal third quarter ending January 25, 2019.
